- Home
- QURE vs MLAB Comparison
QURE vs MLAB Comparison
Compare QURE & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QURE
- MLAB
- Stock Information
- Founded
- QURE 1998
- MLAB 1982
- Country
- QURE Netherlands
- MLAB United States
- Employees
- QURE N/A
- MLAB N/A
- Industry
- QURE Biotechnology: Pharmaceutical Preparations
- MLAB Industrial Machinery/Components
- Sector
- QURE Health Care
- MLAB Industrials
- Exchange
- QURE Nasdaq
- MLAB Nasdaq
- Market Cap
- QURE 750.6M
- MLAB 692.9M
- IPO Year
- QURE 2007
- MLAB N/A
- Fundamental
- Price
- QURE $16.98
- MLAB $132.08
- Analyst Decision
- QURE Strong Buy
- MLAB Hold
- Analyst Count
- QURE 8
- MLAB 2
- Target Price
- QURE $32.43
- MLAB $140.00
- AVG Volume (30 Days)
- QURE 4.7M
- MLAB 44.5K
- Earning Date
- QURE 11-05-2024
- MLAB 02-03-2025
- Dividend Yield
- QURE N/A
- MLAB 0.48%
- EPS Growth
- QURE N/A
- MLAB N/A
- EPS
- QURE N/A
- MLAB N/A
- Revenue
- QURE $28,587,000.00
- MLAB $228,380,000.00
- Revenue This Year
- QURE $150.65
- MLAB $11.32
- Revenue Next Year
- QURE N/A
- MLAB $5.98
- P/E Ratio
- QURE N/A
- MLAB N/A
- Revenue Growth
- QURE N/A
- MLAB 6.88
- 52 Week Low
- QURE $3.73
- MLAB $83.68
- 52 Week High
- QURE $17.71
- MLAB $141.17
- Technical
- Relative Strength Index (RSI)
- QURE 75.89
- MLAB 61.90
- Support Level
- QURE $14.68
- MLAB $127.51
- Resistance Level
- QURE $17.71
- MLAB $138.00
- Average True Range (ATR)
- QURE 1.58
- MLAB 5.25
- MACD
- QURE 0.64
- MLAB 0.80
- Stochastic Oscillator
- QURE 93.71
- MLAB 67.76
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in 4 divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.